As cytotoxic activity of Vδ1 T cells against TRAILR4-KD tumor cells—except for PancTuI cells—was significantly impaired, we asked whether the down-regulation of TRAIL-R4 in these cells led to an altered expression of molecules involved in T cell-mediated cytotoxicity. The gene discussed is TNFRSF10D; the disease is neoplasm.